ETQ Trademark

Trademark Overview


On Wednesday, August 2, 2023, a trademark application was filed for ETQ with the United States Patent and Trademark Office. The USPTO has given the ETQ trademark a serial number of 98114004. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, April 4, 2024. This trademark is owned by Snakestaff Systems LLC. The ETQ trademark is filed in the Medical Instrument Products category with the following description:

Medical devices for use in cannulation or to stem the flow of traumatic bleeding, namely, tourniquets
etq

General Information


Serial Number98114004
Word MarkETQ
Filing DateWednesday, August 2, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, April 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical devices for use in cannulation or to stem the flow of traumatic bleeding, namely, tourniquets

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, August 31, 2023
Primary Code010
First Use Anywhere DateThursday, October 27, 2022
First Use In Commerce DateThursday, October 27, 2022

Trademark Owner History


Party NameSnakestaff Systems LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSouth Salt Lake, UT 84119

Trademark Events


Event DateEvent Description
Saturday, August 5, 2023NEW APPLICATION ENTERED
Thursday, August 31, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 3, 2024ASSIGNED TO EXAMINER
Thursday, April 4, 2024NON-FINAL ACTION WRITTEN
Thursday, April 4, 2024NON-FINAL ACTION E-MAILED
Thursday, April 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 24, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED